Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Selexipag in Congenital Heart Disease–Associated Pulmonary Arterial Hypertension and Eisenmenger Syndrome

First Report

El-Kersh, Karim MD1; Suliman, Sally MD1; Smith, J. Shaun DO2

doi: 10.1097/MJT.0000000000000727
Letters to the Editor
Buy

1Department of Medicine, Division of Pulmonary, Critical Care and Sleep Disorders Medicine, University of Louisville, Louisville, KY

2Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, The Ohio State University Wexner Medical Center, Columbus, OH

Previous abstract presentation: An abstract of this article was presented in ATS 2017, May 23, 2017, Washington, DC.

J. S. Smith: Speaker; Actelion Pharmaceuticals, Bayer, United Therapeutics, and Gilead Sciences. The remaining authors have no conflicts of interest to declare.

All authors contributed to this article.

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.